Facebook Users

Will INMD go up?

INMD IntegraMed America, Inc. featured news, full reports, and detailed charts

IntegraMed America, Inc. (INMD) Wrap Up:

IntegraMed America is a specialty healthcare services company that was incorporated in Delaware on June 4, 1985 and celebrated its fifteenth year as a publicly traded company in 2007. The Company is the leading operator of fertility centers and vein clinics in the United States and provides treatment financing programs for patients of these facilities whose insurance does not cover the particular procedure. The Company is organized into three operating divisions and a Corporate office that provides shared services. The Fertility Centers Division is a provider network comprised of nine contracted fertility centers in our Partner program, located in major markets across the United States. These nine contracted centers are among the largest in the United States accounting for approximately 13% of total U.S. IVF procedures performed. We offer products and services to these providers designed to support the fertility center's growth.  ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f14%2f0000885988-08-000018.html#FIS_BUSINESS"   
www.integramed.com
968 Employees
Founded in 1985

Integramed America Inc. (INMD:NASDAQ)

LAST $7.85 USD
CHANGE TODAY +0.08 1.03%
VOLUME 3.5K
As of 3:59 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).

Snapshot of Integramed America Inc. (INMD)

OPEN
$8.06
PREVIOUS CLOSE
$7.77
DAY HIGH
$8.06
DAY LOW
$7.81
52 WEEK HIGH
09/15/09 - $10.64
52 WEEK LOW
12/5/08 - $4.63
MARKET CAP
68.9M
AVERAGE VOLUME 3 mo
4.4K
DILUTED EPS TTM
$0.46
SHARES OUTSTANDING
8.8M
INMD Does Not Pay Dividends
P/E TTM
17.2x
K = Thousands  M = Millions  B = Billions

INMD Top Compensated Officers

Mr. Jay Higham
Chief Executive Officer, President and Direct...
Age: 50
Total Annual Compensation: $458.7K
Mr. John W. Hlywak Jr.
Chief Financial Officer, Principal Accounting...
Age: 61
Total Annual Compensation: $332.5K
Mr. Scott Soifer
Executive Vice President of Operations and Ad...
Age: 46
Total Annual Compensation: $250.9K
Mr. Joseph J. Travia Jr.
President of Fertility Centers Division
Age: 56
Total Annual Compensation: $355.3K
Ms. Pamela Schumann
President of Consumer Services Division
Age: 43
Total Annual Compensation: $294.0K

Executives, Board Directors

Compensation as of Fiscal Year 2008.

Key developments for Integramed America Inc. (INMD)

Integramed America Inc. announced delayed 10-Q filing

On 11/10/2009, Integramed America Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Fertility Centers Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2009

Fertility Centers reported unaudited earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported operating income of $3.0 million on revenue of $36.0 million compared to operating income of $2.7 million on revenue of $36.5 million for the same period a year ago. For the nine months, the company reported revenue of $109,538,000 compared to revenue of $104,302,000 for the same period a year ago. The company's revenue declined on a year-over-year basis due to the impact of the previously reported loss of a third-party payer contract at one of larger fertility centers at the beginning of the year. That contract loss amounted to approximately $2.0 million in lost revenue. Despite this factor, IntegraMed was able to achieve a 9% improvement in third quarter of 2009 divisional operating income. The improvement reflected an increase in operating margin to 8.3%, compared to 7.5% in the same period of 2008.

Integramed America Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2009; Provides Cash Flow Guidance for the Year 2009

Integramed America Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported net income of $1,228,000 or $0.14 per diluted share on total revenue of $53,598,000 compared to net income of $1,099,000 or $0.13 per diluted share on total revenue of $52,229,000 for the same period a year ago. The company reported income before income taxes of $2,019,000 compared to income before income taxes of $1,826,000 for the same period a year ago. For the nine months, the company reported net income of $3,262,000 or $0.37 per diluted share on total revenue of $162,068,000 compared to net income of $2,834,000 or $0.33 per diluted share on total revenue of $147,933,000 for the same period a year ago. The company reported income before income taxes of $5,435,000 compared to income before income taxes of $4,743,000 for the same period a year ago. Net cash provided by operating activities was $14,181,000 and purchase of fixed assets and leasehold improvements was $4,466,000 compared to net cash provided by operating activities of $5,876,000 and purchase of fixed assets and leasehold improvements of $3,896,000 for the same period a year ago. The company provided cash flow guidance for the year 2009. The company expects to continue building cash from operations for the remainder of 2009.

otc, otcbb, pinksheet, INMD, ob IntegraMed America, Inc.

INMD Competitors

Company Last Change
Continucare Corp $3.08 USD -0.01
Mednax Inc $55.89 USD +0.03
Metropolitan Health Networks Inc $1.97 USD +0.01
UCI Medical Affiliates Inc $2.00 USD 0.00
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation INMD Industry Range
Price/Earnings 17.6x
Price/Sales 0.3x
Price/Book 1.2x
Price/Cash Flow 17.6x
TEV/Sales 0.0x

INMD

 | 

INMD transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent News About IntegraMed America, Inc.

More news for INMD

IntegraMed® Moves Q3 Earnings Release and Conference Call to November 5

PURCHASE, N.Y.--(BUSINESS WIRE)--IntegraMed America, Inc. (NASDAQ: INMD - Newsth. Earnings will be issued pre-market and the conference call will take place at 10:00 a.m. EST. The Company previously planned to release its earnings and host its conference call and webcast on October 30. IntegraMed is moving its earnings date and conference call in order to provide additional time for the Company and its independent auditors to complete a review of the recognition of a portion of deferred revenue within the Company's Consumer Services segment. The contemplated treatment is expected to reduce deferred revenue as of December 31, 2008 by approximately $2.4-$3.0 million and will cause that amount to be recognized in 2008 and prior periods. Recognition of the deferred revenue is not expected to affect previously reported 2009 financial information, nor is it expected to impact future periods. IntegraMed plans to discuss the reasons for the accounting treatment change on its third quarter conference call.Updated details of the Company’s conference call and webcast follow:About IntegraMed America, Inc.IntegraMed America, Inc. manages highly specialized outpatient facilities in emerging, technology-based, niche medical markets and is the leading manager of fertility centers and vein clinics in the United States. IntegraMed supports its provider networks with clinical and busines...
Click here to read the whole Article (external link)

IntegraMed® Announces New Enhanced Consumer Finance Solution for Fertility Treatments

PURCHASE, N.Y.--(BUSINESS WIRE)--IntegraMed America, Inc. (NASDAQ: INMD - News), the nation’s leading manager of specialty outpatient healthcare facilities in the emerging, technology-focused medical niches of fertility and vein care, today announced that it has partnered with Springstone Financial LLC to provide IntegraMed Fertility Network patients with improved financing options to fund Attain IVF Programs and certain other fertility treatments. Financing programs will be available to IntegraMed Fertility Network patients starting later this month. Building on its deep industry expertise and unique position within the fertility markets, IntegraMed was able to recognize a need for alternative treatment financing options for both patients seeking fertility treatment and the practices that serve them, and come to market with a product that better meets the demands and needs of its network centers and patients.Working with Springstone Financial, IntegraMed will be offering flexible installment loan financing for fertility procedures, supported by enhanced customer service, on-line capabilities, and consumer friendly terms.Pamela Schumann, President of the Consumer Services Division of IntegraMed, commented, “This is a significant step in resolving both the challenges faced by our Consumer Services division when our principle lender exited the medical treatment financing businesses an...
Click here to read the whole Article (external link)

INTEGRAMED AMERICA INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review

Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. On October 28, 2009, the management of IntegraMed America, Inc. (the "Company") concluded and subsequently reported to the Audit Committee of the Company's Board of Directors (the "Audit Committee") that the Company's audited financial statements for the years ended December 31, 2006, 2007 and 2008 (collectively, the "Relevant Periods") should no longer be relied upon and will be restated due to an understatement in revenue recognized in connection with its Attain IVF program within its Consumer Services Division. As previously reported on a Current Report on Form 8-K filed on March 31, 2009, the Company restated certain financial statements after determining that they could not be relied upon. Specifically, the Company restated its prior financial statements with respect to the timing of revenue recognition related to its Attain IVF program (formerly "Shared Risk Refund Program") within its Consumer Services Division. That restatement did not impact the cash flows from operations of this program or the ultimate profits to be recognized, only the timing of the revenue recognition for a portion of the fees that we collect from our customer. Subsequent to the original restatement, the Company developed, programmed and tested a new patient management and revenue recognition system for the Attain IVF program. The new system recently reached sufficient operating proficiency to allow input of the patient information related to the Attain IVF program. As a result, the Company identified that the deferred revenue amount that had been previously restated did not take into account the remaining non-refundable portion of the patient fee earned when a patient dropped out of the program. The Company determined that while the previous system properly accounted for the recognition of the proportional fair value revenue related to t...
Click here to read the whole Article (external link)

INTEGRAMED AMERICA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex

Show all filings for INTEGRAMED AMERICA INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for INTEGRAMED AMERICA INC 29-Oct-2009Results of Operations and Financial Condition, Financial Statements and Ex Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information pr...
Click here to read the whole Article (external link)

Q3 2009 IntegraMed America, Inc. Earnings Release - Before Market Open

Earnings Announcements for Thursday, November 5CompanySymbolTimeConferenceCall21st Century HoldingTCHC2:00 pm ET3I INFRASTRUCTURE3IN.LBefore Market OpenAbiomed, Inc.ABMDBefore Market OpenListenABOVENET INCABVTAfter Market CloseListenAbraxis BioScience, Inc.ABIIBefore Market OpenListenAccelrys Inc.ACCLAfter Market CloseListenACI Worldwide, Inc.ACIWBefore Market OpenACTIONS SEMICONDUCTOR CO LTDACTSAfter Market CloseActive Biotech ABACTI.STTime Not SuppliedActivision Blizzard, Inc.ATVIAfter Market CloseAdecco SAAHEXF.PK01:00 am ETAinsworth Lumber Company Ltd.ANS.TOAfter Market CloseAir MethodsAIRMAfter Market CloseAker ASAAKERTime Not SuppliedALAMOS GOLD INCAGI.TOBefore Market OpenAlaska Communications Systems GroupALSKAfter Market CloseAlexandria Real Estate...
Click here to read the whole Article (external link)

IntegraMed® Q3 EPS Grew 8% to $0.14 on a 3% Increase in Total Revenue to $53.6 Million

        INTEGRAMED AMERICA, INC.   CONSOLIDATED STATEMENT OF OPERATIONS (all amounts in thousands, except per share amounts) (Unaudited)     For the For the three-month ...
Click here to read the whole Article (external link)

IntegraMed America, Inc. Earnings Call scheduled for 10:00 am ET today

Call DetailsIntegraMed America, Inc. Earnings Conference Call (Q3 2009)Thu, Nov 5, 2009, 10:00 am EasternAbout IntegraMed America, Inc. (NasdaqGM:INMD)IntegraMed America, Inc., a specialty healthcare services company, offers products and services to patients and providers in the fertility and vein care segments of the health industry in the United States. It operates in three segments: Fertility Centers, Consumer Services, and Vein Clinics. The Fertility Centers segment, as of December 31, 2008, operated a network of 33 contracted fertility centers in the United States. It offers products and services designed to support the fertility center's growth. The Consumer Services segment offers products directly to fertility patients. It provides Shared Risk Refund program under the Attain IVF name; and financing programs that are designed for patients. This segment maintained a contracted network of 22 independent fertility clinics under its affiliate program designed to distribute the segment's products and services to patients. The Vein Clinics segment provides business and management services to a network of 32 clinics located in 12 states that provide specialized treatment for patients suffering from vein diseases and disorders. The company was founded in 1985 and is headquartered in Purchase, New York.More Info:Quote |Chart |News |Profile |Reports |Research |SEC |...
Click here to read the whole Article (external link)

INTEGRAMED AMERICA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex

Show all filings for INTEGRAMED AMERICA INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for INTEGRAMED AMERICA INC 5-Nov-2009Results of Operations and Financial Condition, Financial Statements and Ex Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information pro...
Click here to read the whole Article (external link)

INTEGRAMED AMERICA INC Files SEC form 10-Q, Quarterly Report

Show all filings for INTEGRAMED AMERICA INC | Request a Trial to NEW EDGAR Online Pro Form 10-Q for INTEGRAMED AMERICA INC 16-Nov-2009Quarterly Report Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended f...
Click here to read the whole Article (external link)

IntegraMed America, Inc. Q3 2009 Earnings Call Transcript

IntegraMed America, Inc. (INMD) Q3 2009 Earnings Call Transcript November 5, 2009 10:00 am ET Executives Jay Higham - President and CEO John Hlywak - EVP and CFO Analysts Greg Williams - Sidoti Presentation Operator Good morning. My name is Kimberly, and I will be your conference operator today. At this time I would like to welcome everyone to the IntegraMed third quarter 2009 investor conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session. (Operator instructions). Thank you. I will now turn the call over to John Hlywak. John Hlywak Good morning. This is John Hlywak, Executive Vice President and CFO of IntegraMed. Thank you for participating in today's call. Joining me today is Jay Higham, President and Chief Executive Officer. Before we begin, I'd like to caution that comments made during this conference call by management may contain forward-looking statements that involve risks and uncertainties regarding the operations and future results of IntegraMed. I encourage you to review the Company's filings with the Securities and Exchange Commission, including without limitation, the Company's Form 10-K and Form 10-Qs, which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. The content in this conference call contains time-sensitive information that is accurate only as of today, August 6, 2009. IntegraMed undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this conference call. With that I'll now turn the call over to Jay, President and CEO...
Click here to read the whole Article (external link)

Would you like to leave a comment about IntegraMed America, Inc. INMD

Besides IntegraMed America, Inc. there is more great information available at Realpennies.com